Home › Type 2 Diabetes › Ohio › Cleveland
Type 2 Diabetes clinical trials in Cleveland, OH
6 studies for Type 2 Diabetes are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Beachwood · 10 mi away
Imaging in Semaglutide Study
RecruitingObservational study
- Cleveland Clinic, Cleveland
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Cleveland
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RecruitingPhase 3
- Cleveland Clinic Childrens Outpatient Center, Cleveland
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
Recruiting
- Cleveland Clinic Foundation, Cleveland
Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics
RecruitingEarly phase 1
- Case Western Reserve University, Cleveland
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Atlanta, GA21 studies
- San Diego, CA21 studies
- Boston, MA20 studies
- Miami, FL20 studies
- Chicago, IL19 studies
- Arlington, VA19 studies
- Los Angeles, CA18 studies
- Dallas, TX18 studies
- Columbus, OH17 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Heart Failure31 studies
- Metastatic Cancer30 studies
- Prostate Cancer30 studies
- Ovarian Cancer29 studies
- Lung Cancer26 studies
- Colorectal Cancer25 studies
- Acute Myeloid Leukemia20 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Cardiovascular Disease20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.